Novavax Analyst Turns Uber-Bullish, Raises Price Target To $10
January 10, 2018 at 11:53 AM EST
Analysts at B. Riley FBR initiated coverage of Novavax, Inc. (NASDAQ: NVAX) on Jan. 5 with a Buy rating and $2.25 price target. Just ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.